EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 32 / No 6-7 (Juin–Juillet 2016) Med Sci (Paris), 32 6-7 (2016) 648-649 References
Free Access
This article is a note for:
[https://doi.org/10.1051/medsci/20163204019]

Issue
Med Sci (Paris)
Volume 32, Number 6-7, Juin–Juillet 2016
Page(s) 648 - 649
Section Forum
DOI https://doi.org/10.1051/medsci/20163206031
Published online 12 July 2016
  1. Lysy P. La thérapie cellulaire du diabète : le point sur les actualités. Med Sci (Paris) 2016 ; 32 : 401–407. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. International Societey for stem cell research. Guidelines for stem cell research and clinical trasnlation. May 2016. http://www.isscr.org/docs/default-source/guidelines/isscr-guidelines-for-stem-cell-research-and-clinical-translation.pdf?sfvrsn=2 [Google Scholar]
  3. Wu SM, Hochedlinger K Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol 2011 ; 13 : 497–505. [CrossRef] [PubMed] [Google Scholar]
  4. Trounson A, DeWitt ND Pluripotent stem cells progressing to the clinic. Nat Rev Mol Biol 2016 ; 17 : 194–200. [CrossRef] [Google Scholar]
  5. Kimbrel EA, Lanza R Current status of pluripotent stem cells: moving the first therapies to the clinic. Nat Rev Drug Discov 2015 ; 14 : 681–692. [CrossRef] [PubMed] [Google Scholar]
  6. Schwartz SD, Tan G, Hosseini H, Nagiel A. Subretinal transplantation of embryonic stem cell-derived retinal pigment epithelium for the treatment of macular degeneration: an assessment at 4 years. Invest Ophthalmol Vis Sci 2016 ; 57 : ORSFc1-9. [CrossRef] [PubMed] [Google Scholar]
  7. Song WK, Park KM, Kim HJ, et al. Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients. Stem Cell Reports 2015 ; 4 : 860–872. [CrossRef] [PubMed] [Google Scholar]
  8. Lebkowski JS. Phase I clinical trial of human embryonic stem cell derived oligodendrocyte progenitors in patients with neurologically complete thoracic spinal cord injury: results and next steps. American Society for Cell and Gene Therapy conference 2014 (http://asteriasbiotherapeutics.com/pipeline/ast-opc1/) [Google Scholar]
  9. Menasché P, Vanneaux V, Hagège A, et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J 2015 ; 36 : 2011–2017. [CrossRef] [PubMed] [Google Scholar]
  10. Agulnick AD, Ambruzs DM, Moorman MA, et al. Insulin-producing endocrine cells differentiated in vitro from human embryonic stem cells function in macroencapsulation devices in vivo. Stem Cells Transl Med 2015 ; 4 : 1214–1222. [CrossRef] [PubMed] [Google Scholar]
  11. Kunjom Mfopou J, Bouwens L. Différenciation des cellules souches pluripotentes en cellules pancréatiques. Med Sci (Paris) 2013 ; 29 : 736–743. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  12. Vieira A, Druelle N, Courtney M, et al. Reprogrammation des cellules pancréatiques en cellules β. Med Sci (Paris) 2013 ; 29 : 749–755. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.